Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryAug 31, 2015	Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial Company on Track to Complete Study Enrollment for Its Combined Hormonal Contraceptive Patch by the End of Third Quarter 2015...	Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial 18.9 KB
Toggle SummaryAug 27, 2015	Agile Therapeutics Announces Presentation at Upcoming Conferences PRINCETON, N.J. , Aug. 27, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that management will present at the following...	Agile Therapeutics Announces Presentation at Upcoming Conferences 15 KB
Toggle SummaryAug 13, 2015	Agile Therapeutics Reports Second Quarter Financial Results Continues to Progress Clinical Trial; Patents for Proprietary Platform to Develop New Women's Contraceptive Products Allowed...	Agile Therapeutics Reports Second Quarter Financial Results 27.4 KB
Toggle SummaryJul 23, 2015	Agile Therapeutics Announces Allowance of Several Patents on Novel Dosing Regimens for Its Pipeline of Follow-On Contraceptive Products Intellectual Property Portfolio Significantly Broadened for Its Proprietary Transdermal Delivery System...	Agile Therapeutics Announces Allowance of Several Patents on Novel Dosing Regimens for Its Pipeline of Follow-On Contraceptive Products 17.5 KB
Toggle SummaryJul 1, 2015	Agile Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference Presentation Scheduled on Wednesday, July 8th, 2015 at 11:15 AM ET...	Agile Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference 15.2 KB
Toggle SummaryJun 30, 2015	Agile Therapeutics Added to Membership of Russell 2000(R), 3000(R) and Global Indexes PRINCETON, N.J., June 30, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that its stock has been selected for addition to...	Agile Therapeutics Added to Membership of Russell 2000(R), 3000(R) and Global Indexes 15.7 KB
Toggle SummaryJun 15, 2015	Agile Therapeutics to Present at the JMP Securities Life Sciences Conference 2015 Presentation Scheduled on Tuesday, June 23th, 2015 at 9:00 AM ET...	Agile Therapeutics to Present at the JMP Securities Life Sciences Conference 2015 15.2 KB
Toggle SummaryJun 12, 2015	Agile Therapeutics Announces Issuance of Patent for Twirla(R) Patch Design Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System...	Agile Therapeutics Announces Issuance of Patent for Twirla(R) Patch Design 16.3 KB
Toggle SummaryMay 28, 2015	Agile Therapeutics to Present at the William Blair 35th Annual Growth Stock Conference Presentation Scheduled on Tuesday, June 9, 2015 at 2:10 PM Central Time...	Agile Therapeutics to Present at the William Blair 35th Annual Growth Stock Conference 15.1 KB
Toggle SummaryMay 12, 2015	Agile Therapeutics Reports First Quarter Financial Results SECURE Trial Continues to Progress...	Agile Therapeutics Reports First Quarter Financial Results 25.3 KB